Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neonatal, Clinical and Neurodevelopmental Outcome of Neonates Hospitalized for Neonatal Hyperbilirubinemia Reaching Exchange Transfusion Threshold in a Remote Setting Along the Thai-Myanmar Border

NCT02927093 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02927093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neonatal, Clinical and Neurodevelopmental Outcome of Neonates Hospitalized for Neonatal Hyperbilirubinemia Reaching Exchange Transfusion Threshold in a Remote Setting Along the Thai-Myanmar Border
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Completed
Start date
October 31, 2016
Completion date
March 31, 2017
Enrollment
78 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal hyperbilirubinemia